Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Management of asthma during pregnancy

Michael Schatz, MD, MS
Steven E Weinberger, MD
Section Editors
Bruce S Bochner, MD
Charles J Lockwood, MD, MHCM
Deputy Editor
Helen Hollingsworth, MD


Asthma is one of the most common medical conditions encountered during pregnancy, occurring in 3 to 8 percent of pregnant women [1-5]. Pregnancy may be associated with changes in the course of asthma, and asthma may affect the outcome of pregnancy.

The management of asthma in pregnancy, including general management issues, the safety data for specific asthma medications, and recommended pharmacotherapy for acute and chronic asthma in pregnancy, is reviewed here. The physiology and clinical course of asthma in pregnancy are discussed separately. (See "Physiology and clinical course of asthma in pregnancy".)


Two important considerations arise with the use of any medication in pregnancy:

Are there potential adverse effects of the medication on the developing fetus?

Does pregnancy alter the metabolism or the bioavailability of the medication?


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2016. | This topic last updated: Dec 17, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Namazy JA, Schatz M. Pregnancy and asthma: recent developments. Curr Opin Pulm Med 2005; 11:56.
  2. Liccardi G, Cazzola M, Canonica GW, et al. General strategy for the management of bronchial asthma in pregnancy. Respir Med 2003; 97:778.
  3. Tan KS, Thomson NC. Asthma in pregnancy. Am J Med 2000; 109:727.
  4. Dombrowski MP, Schatz M, Wise R, et al. Asthma during pregnancy. Obstet Gynecol 2004; 103:5.
  5. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 2003; 13:317.
  6. Schatz, M, Dombrowski, M. Outcomes of pregnancy in asthmatic women. Immunol Allergy Clin North Am 2000; 20:715.
  7. Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 2008; 63:981.
  8. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997; 100:301.
  9. Correa A, Cragan JD, Kucik JE, et al. Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol 2007; 79:65.
  10. Källén B, Rydhstroem H, Aberg A. Asthma during pregnancy--a population based study. Eur J Epidemiol 2000; 16:167.
  11. Scialli A, Lone A. Pregnancy effects of specific medications used to treat asthma and immunological diseases. In: Asthma and immunological diseases in pregnancy and early infancy, Schatz M, Zeiger RS, Claman HN (Eds), Marcel Dekker, New York 1998.
  12. Petitti, DB. Perinatal epidemiology: Studying the effects of illness and medications during pregnancy. Immunol Allergy Clin North Am 2000; 20:673.
  13. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy, PSG Publishing, Littleton, MA 1977.
  14. Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 2004; 113:1040.
  15. Specific requirements on content and format of labeling for human prescription drugs. Fed Reg 1979; 44:37462.
  16. Scialli AR, Buelke-Sam JL, Chambers CD, et al. Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs. Birth Defects Res A Clin Mol Teratol 2004; 70:7.
  17. Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999; 93:392.
  18. Polifka, JE, Jones, KL. General considerations regarding the use of asthma and allergy medications during pregnancy. Immunol Allergy Clin North Am 2000; 20:687.
  19. Kweder SL. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Birth Defects Res A Clin Mol Teratol 2008; 82:605.
  20. Namazy JA, Schatz M. Update in the treatment of asthma during pregnancy. Clin Rev Allergy Immunol 2004; 26:139.
  21. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005; 115:34.
  22. Schatz M, Dombrowski MP, Wise R, et al. Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol 2006; 194:120.
  23. Schatz M, Zeiger RS, Hoffman CP. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group. Chest 1990; 98:389.
  24. Newman RB, Momirova V, Dombrowski MP, et al. The effect of active and passive household cigarette smoke exposure on pregnant women with asthma. Chest 2010; 137:601.
  25. Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax 2010; 65:739.
  26. Blais L, Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol 2008; 121:1379.
  27. Schatz, M, Hoffman, CP, Zeiger, RS, et al. Asthma and allergic diseases during pregnancy. In: Middleton's Allergy: Principles and Practice, 6th, Adkinson, NF, Yunginger, JW, Busse, WW, et al (Eds), Mosby, St. Louis, MO 2003. p.1303.
  28. Brown, WA. Psychological care during pregnancy and the postpartum period, Raven Press, New York 1979.
  29. Schatz M. The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 2001; 25:145.
  30. Bracken MB, Triche EW, Belanger K, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 2003; 102:739.
  31. Namazy J, Schatz M, Long L, et al. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol 2004; 113:427.
  32. Schatz M. Asthma and pregnancy. Lancet 1999; 353:1202.
  33. Dombrowski MP, Schatz M, ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol 2008; 111:457.
  34. Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS. Asthma drugs and the risk of congenital anomalies. Pharmacotherapy 2013; 33:363.
  35. Bain E, Pierides KL, Clifton VL, et al. Interventions for managing asthma in pregnancy. Cochrane Database Syst Rev 2014; :CD010660.
  36. Namazy JA, Chambers C, Schatz M. Safety of therapeutic options for treating asthma in pregnancy. Expert Opin Drug Saf 2014; 13:1613.
  37. GINA report. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). www.ginasthma.org (Accessed on December 08, 2015).
  38. Lim A, Stewart K, König K, George J. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother 2011; 45:931.
  39. Schatz M, Zeiger RS, Harden KM, et al. The safety of inhaled beta-agonist bronchodilators during pregnancy. J Allergy Clin Immunol 1988; 82:686.
  40. Stenius-Aarniala B, Riikonen S, Teramo K. Slow-release theophylline in pregnant asthmatics. Chest 1995; 107:642.
  41. Wilson, I. Utilisation du cromoglycate de sodium au cours de la grossesse. Acta Therapeutica 1982; 8:45S.
  42. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol 2003; 111:736.
  43. Lin S, Munsie JP, Herdt-Losavio ML, et al. Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol 2008; 168:73.
  44. Garne E, Hansen AV, Morris J, et al. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study. J Allergy Clin Immunol 2015; 136:1496.
  45. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol 2007; 63:383.
  46. http://www.reprotox.org/Members/AgentDetail.aspx?a=3721 (Accessed on May 06, 2011).
  47. http://www.reprotox.org/Members/AgentDetail.aspx?a=4360 (Accessed on May 06, 2011).
  48. Wilton LV, Shakir SA. A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England. Drug Saf 2002; 25:213.
  49. The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). Ann Allergy Asthma Immunol 2000; 84:475.
  50. Schatz M, Dombrowski MP. Clinical practice. Asthma in pregnancy. N Engl J Med 2009; 360:1862.
  51. Eltonsy S, Forget A, Beauchesne MF, Blais L. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol 2015; 135:123.
  52. Bakhireva LN, Jones KL, Schatz M, et al. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 2005; 116:503.
  53. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986; 78:349.
  54. Schatz M, Patterson R, Zeitz S, et al. Corticosteroid therapy for the pregnant asthmatic patient. JAMA 1975; 233:804.
  55. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62:385.
  56. Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004; 18:93.
  57. Perlow JH, Montgomery D, Morgan MA, et al. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992; 167:963.
  58. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202:436.
  59. Namazy JA, Murphy VE, Powell H, et al. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J 2013; 41:1082.
  60. Stenius-Aarniala B, Piirilä P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988; 43:12.
  61. Martel MJ, Rey E, Beauchesne MF, et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ 2005; 330:230.
  62. Greenberger PA, Patterson R. Beclomethasone diproprionate for severe asthma during pregnancy. Ann Intern Med 1983; 98:478.
  63. Dombrowski MP, Brown CL, Berry SM. Preliminary experience with triamcinolone acetonide during pregnancy. J Matern Fetal Med 1996; 5:310.
  64. Dombrowski MP, Schatz M, Wise R, et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol 2004; 190:737.
  65. Dombrowski M, Thom E, McNellis D. Maternal-Fetal Medicine Units (MFMU) studies of inhaled corticosteroids during pregnancy. J Allergy Clin Immunol 1999; 103:S356.
  66. Blais L, Beauchesne MF, Rey E, et al. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 2007; 62:320.
  67. Blais L, Beauchesne MF, Lemière C, Elftouh N. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol 2009; 124:1229.
  68. Breton MC, Beauchesne MF, Lemière C, et al. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy. J Allergy Clin Immunol 2010; 126:772.
  69. Hodyl NA, Stark MJ, Osei-Kumah A, et al. Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy. Am J Respir Crit Care Med 2011; 183:716.
  70. Tegethoff M, Greene N, Olsen J, et al. Inhaled glucocorticoids during pregnancy and offspring pediatric diseases: a national cohort study. Am J Respir Crit Care Med 2012; 185:557.
  71. Van Zutphen AR, Bell EM, Browne ML, et al. Maternal asthma medication use during pregnancy and risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol 2015; 103:951.
  72. Charlton RA, Snowball JM, Nightingale AL, Davis KJ. Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract 2015; 3:772.
  73. Wendel PJ, Ramin SM, Barnett-Hamm C, et al. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996; 175:150.
  74. National Asthma Education and Prevention Program Expert Panel Executive Summary Report: Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. National Institutes of Health, National Heart, Lung, and Blood Institute, Publication No. 02-5075, 2002. www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf (Accessed on March 1, 2006).
  75. Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007; 119:618.
  76. Sarkar M, Koren G, Kalra S, et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol 2009; 65:1259.
  77. Reprotox. http://www.reprotox.org/Members/AgentDetail.aspx?a=4087 (Accessed on May 06, 2011).
  78. Reprotox. http://www.reprotox.org/Members/AgentDetail.aspx?a=3993 (Accessed on May 06, 2011).
  79. Reprotox. http://www.reprotox.org/Members/AgentDetail.aspx?a=3722.
  80. Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015; 135:407.
  81. Neff RK, Leviton A. Maternal theophylline consumption and the risk of stillbirth. Chest 1990; 97:1266.
  82. Connelly TJ, Ruo TI, Frederiksen MC, Atkinson AJ Jr. Characterization of theophylline binding to serum proteins in pregnant and nonpregnant women. Clin Pharmacol Ther 1990; 47:68.
  83. Carter BL, Driscoll CE, Smith GD. Theophylline clearance during pregnancy. Obstet Gynecol 1986; 68:555.
  84. Labovitz E, Spector S. Placental theophylline transfer in pregnant asthmatics. JAMA 1982; 247:786.
  85. Bucher HU, Gautschi K. [Detection of caffeine, theophylline and theobromine in the umbilical cord blood and breast milk]. Helv Paediatr Acta 1985; 40:163.
  86. National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on December 04, 2014).
  87. Quick Reference. NAEPP Expert Panel Report Managing Asthma During Pregnancy: Recommendations for Phamacologic Treatment—Update 2004 NIH Publication No. 04-5246. US Dept of Health and human Services, Bethesda, MD, 2004.
  88. Ericson, A, Kallen, B. Use of drugs during pregnancy—unique Swedish registration method can be improved. Information from the Swedish Medical Products Agency 1999; 1:9.
  89. Cydulka RK. Acute asthma during pregnancy. Immunol Allergy Clin North Am 2006; 26:103.
  90. Management of asthma during pregnancy: Report of the Working Group on Asthma and Pregnancy NIH Publication No. 93-3279. National Asthma Education Program; National Institutes of Health, Bethesda, MD, 1993.
  91. Schatz, M, Wise, RA. Acute asthma in pregnancy. In: Acute Asthma: Assessment and Management, Corbridge T, et al (Eds), McGraw-Hill, New York 2000.
  92. Minerbi-Codish I, Fraser D, Avnun L, et al. Influence of asthma in pregnancy on labor and the newborn. Respiration 1998; 65:130.
  93. Arakawa H, Lötvall J, Kawikova I, et al. Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor. Br J Pharmacol 1993; 110:127.
  94. Kawikova I, Barnes PJ, Takahashi T, et al. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 1996; 153:590.
  95. Towers CV, Briggs GG, Rojas JA. The use of prostaglandin E2 in pregnant patients with asthma. Am J Obstet Gynecol 2004; 190:1777.